Cargando…

Cognitive dysfunction in autoimmune rheumatic diseases

For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Oláh, Csaba, Schwartz, Noa, Denton, Christopher, Kardos, Zsófia, Putterman, Chaim, Szekanecz, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158026/
https://www.ncbi.nlm.nih.gov/pubmed/32293528
http://dx.doi.org/10.1186/s13075-020-02180-5
_version_ 1783522454647341056
author Oláh, Csaba
Schwartz, Noa
Denton, Christopher
Kardos, Zsófia
Putterman, Chaim
Szekanecz, Zoltán
author_facet Oláh, Csaba
Schwartz, Noa
Denton, Christopher
Kardos, Zsófia
Putterman, Chaim
Szekanecz, Zoltán
author_sort Oláh, Csaba
collection PubMed
description For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD). In RA, CD has been associated with age, lower education and disease duration and activity. Great advances have been achieved in neuropsychiatric SLE in the identification of pathogenic pathways, assessment and possible treatment strategies. SSc rarely exerts direct effects on the brain and cognitive function. However, the psychological burden that includes depression, anxiety and social impact may be high. AIRD patients with sustained disease activity, organ damage or lower education should be evaluated for CD. The control of systemic inflammation together with tailored behavioural cognitive therapies may benefit these patients.
format Online
Article
Text
id pubmed-7158026
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71580262020-04-20 Cognitive dysfunction in autoimmune rheumatic diseases Oláh, Csaba Schwartz, Noa Denton, Christopher Kardos, Zsófia Putterman, Chaim Szekanecz, Zoltán Arthritis Res Ther Review For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD). In RA, CD has been associated with age, lower education and disease duration and activity. Great advances have been achieved in neuropsychiatric SLE in the identification of pathogenic pathways, assessment and possible treatment strategies. SSc rarely exerts direct effects on the brain and cognitive function. However, the psychological burden that includes depression, anxiety and social impact may be high. AIRD patients with sustained disease activity, organ damage or lower education should be evaluated for CD. The control of systemic inflammation together with tailored behavioural cognitive therapies may benefit these patients. BioMed Central 2020-04-15 2020 /pmc/articles/PMC7158026/ /pubmed/32293528 http://dx.doi.org/10.1186/s13075-020-02180-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Oláh, Csaba
Schwartz, Noa
Denton, Christopher
Kardos, Zsófia
Putterman, Chaim
Szekanecz, Zoltán
Cognitive dysfunction in autoimmune rheumatic diseases
title Cognitive dysfunction in autoimmune rheumatic diseases
title_full Cognitive dysfunction in autoimmune rheumatic diseases
title_fullStr Cognitive dysfunction in autoimmune rheumatic diseases
title_full_unstemmed Cognitive dysfunction in autoimmune rheumatic diseases
title_short Cognitive dysfunction in autoimmune rheumatic diseases
title_sort cognitive dysfunction in autoimmune rheumatic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158026/
https://www.ncbi.nlm.nih.gov/pubmed/32293528
http://dx.doi.org/10.1186/s13075-020-02180-5
work_keys_str_mv AT olahcsaba cognitivedysfunctioninautoimmunerheumaticdiseases
AT schwartznoa cognitivedysfunctioninautoimmunerheumaticdiseases
AT dentonchristopher cognitivedysfunctioninautoimmunerheumaticdiseases
AT kardoszsofia cognitivedysfunctioninautoimmunerheumaticdiseases
AT puttermanchaim cognitivedysfunctioninautoimmunerheumaticdiseases
AT szekaneczzoltan cognitivedysfunctioninautoimmunerheumaticdiseases